{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:38:16Z","timestamp":1784302696562,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["450\/2024"],"award-info":[{"award-number":["450\/2024"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["384\/2024"],"award-info":[{"award-number":["384\/2024"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"DOI":"10.1007\/s00726-026-03499-0","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:16:34Z","timestamp":1770466594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tryptophan metabolites clearance in hemodialyzed patients"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5251-7763","authenticated-orcid":false,"given":"Izabela","family":"Zakrocka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7399-8340","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Mlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3732-4336","authenticated-orcid":false,"given":"Natalia","family":"Moniczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3124-6241","authenticated-orcid":false,"given":"Sylwia","family":"Boczkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Kloc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7587-2626","authenticated-orcid":false,"given":"Tomasz","family":"Kocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2704-528X","authenticated-orcid":false,"given":"Ewa M.","family":"Urba\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6043-3236","authenticated-orcid":false,"given":"Wojciech","family":"Za\u0142uska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-2946","authenticated-orcid":false,"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"8","key":"3499_CR1","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/ndt\/gfaf024","volume":"40","author":"Y Battaglia","year":"2025","unstructured":"Battaglia Y, Shroff R, Meijers B et al (2025) Haemodiafiltration versus high-flux haemodialysis\u2014a consensus statement from the EuDial working group of the ERA. Nephrol Dial Transpl 40(8):1590\u20131614. https:\/\/doi.org\/10.1093\/ndt\/gfaf024","journal-title":"Nephrol Dial Transpl"},{"key":"3499_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/s0140-6736(87)90266-2","volume":"1","author":"J Bergstr\u00f6m","year":"1987","unstructured":"Bergstr\u00f6m J, Wehle B (1987) No change in corrected beta 2-microglobulin concentration after Cuprophane haemodialysis. Lancet (London England) 1:628\u2013629. https:\/\/doi.org\/10.1016\/s0140-6736(87)90266-2","journal-title":"Lancet (London England)"},{"key":"3499_CR3","doi-asserted-by":"publisher","unstructured":"Boenink R, Bonthuis M, Boerstra BA et al (2025) The ERA Registry Annual Report 2022: Epidemiology of Kidney Replacement Therapy in Europe, with a focus on sex comparisons. Clin Kidney J 18:sfae405. https:\/\/doi.org\/10.1093\/ckj\/sfae405","DOI":"10.1093\/ckj\/sfae405"},{"key":"3499_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1525-1594.2005.29047.x","volume":"29","author":"M Bossola","year":"2005","unstructured":"Bossola M, Muscaritoli M, Tazza L et al (2005) Switch from bicarbonate hemodialysis to hemodiafiltration with online regeneration of the ultrafiltrate (HFR): effects on nutritional status, microinflammation, and beta-microglobulin. Artif Organs 29:259\u2013263. https:\/\/doi.org\/10.1111\/j.1525-1594.2005.29047.x","journal-title":"Artif Organs"},{"key":"3499_CR5","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/ckj\/sfaa216","volume":"14","author":"P Ciceri","year":"2021","unstructured":"Ciceri P, Tettamanti G, Galassi A et al (2021) Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over study. Clin Kidney J 14:1798\u20131807. https:\/\/doi.org\/10.1093\/ckj\/sfaa216","journal-title":"Clin Kidney J"},{"key":"3499_CR6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/ndt\/gfv038","volume":"30","author":"T Cornelis","year":"2015","unstructured":"Cornelis T, Eloot S, Vanholder R et al (2015) Protein-bound uraemic toxins, dicarbonyl stress and advanced glycation end products in conventional and extended haemodialysis and haemodiafiltration. Nephrol Dial Transpl 30:1395\u20131402. https:\/\/doi.org\/10.1093\/ndt\/gfv038","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"3499_CR7","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ekir.2025.02.024","volume":"10","author":"C El Chamieh","year":"2025","unstructured":"El Chamieh C, Liabeuf S, Larabi IA et al (2025) Uncovering the link between kynurenic acid pathway and kidney failure. Kidney Int Rep 10(5):1404\u20131414. https:\/\/doi.org\/10.1016\/j.ekir.2025.02.024","journal-title":"Kidney Int Rep"},{"key":"3499_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1440-1681.1986.tb02380.x","volume":"13","author":"MJ Fregly","year":"1986","unstructured":"Fregly MJ, Fater DC (1986) Prevention of DOCA-induced hypertension in rats by chronic treatment with tryptophan. Clin Exp Pharmacol Physiol 13:767\u2013776. https:\/\/doi.org\/10.1111\/j.1440-1681.1986.tb02380.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"3499_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/toxins13030223","volume":"13","author":"J Fryc","year":"2021","unstructured":"Fryc J, Naumnik B (2021) Thrombolome and its emerging role in chronic kidney diseases. Toxins (Basel) 13(3):223. https:\/\/doi.org\/10.3390\/toxins13030223","journal-title":"Toxins (Basel)"},{"key":"3499_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/s0378-4347(00)83925-0","volume":"428","author":"MP Heyes","year":"1988","unstructured":"Heyes MP, Quearry BJ (1988) Quantification of 3-hydroxykynurenine in brain by high-performance liquid chromatography and electrochemical detection. J Chromatogr 428:340\u2013344. https:\/\/doi.org\/10.1016\/s0378-4347(00)83925-0","journal-title":"J Chromatogr"},{"issue":"2","key":"3499_CR11","doi-asserted-by":"publisher","first-page":"F199","DOI":"10.1152\/ajprenal.00019.2024","volume":"327","author":"DL Irsik","year":"2024","unstructured":"Irsik DL, Chen J-K, Bollag WB, Isales CM (2024) Chronic infusion of the tryptophan metabolite, kynurenine increases mean arterial pressure in male Sprague Dawley rats. Am J Physiol Physiol 327(2):F199\u2013F207. https:\/\/doi.org\/10.1152\/ajprenal.00019.2024","journal-title":"Am J Physiol Physiol"},{"key":"3499_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12882-015-0100-y","volume":"16","author":"S Kalim","year":"2015","unstructured":"Kalim S, Clish CB, Deferio JJ et al (2015) Cross-sectional examination of metabolites and metabolic phenotypes in uremia. BMC Nephrol 16:98. https:\/\/doi.org\/10.1186\/s12882-015-0100-y","journal-title":"BMC Nephrol"},{"key":"3499_CR13","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.3390\/jcm10112484","volume":"10","author":"M Kiluk","year":"2021","unstructured":"Kiluk M, Lewkowicz J, Pawlak D, Tankiewicz-Kwedlo A (2021) Crosstalk between tryptophan metabolism via kynurenine pathway and carbohydrate metabolism in the context of cardio-metabolic risk\u2014review. J Clin Med 10:2484. https:\/\/doi.org\/10.3390\/jcm10112484","journal-title":"J Clin Med"},{"issue":"11","key":"3499_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/toxins14110779","volume":"14","author":"YG Kim","year":"2022","unstructured":"Kim YG, Lee SH, Jung SW et al (2022) The medium cut-off membrane does not lower protein-bound uremic toxins. Toxins (Basel) 14(11):779. https:\/\/doi.org\/10.3390\/toxins14110779","journal-title":"Toxins (Basel)"},{"key":"3499_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00702-011-0668-8","volume":"119","author":"T Kocki","year":"2012","unstructured":"Kocki T, Wnuk S, Kloc R et al (2012) New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid\/3-hydroxykynurenine ratio. J Neural Transm 119:235\u2013243. https:\/\/doi.org\/10.1007\/s00702-011-0668-8","journal-title":"J Neural Transm"},{"key":"3499_CR16","doi-asserted-by":"publisher","first-page":"112951","DOI":"10.1016\/j.nut.2025.112951","volume":"141","author":"G Kosmadakis","year":"2026","unstructured":"Kosmadakis G, Necoara A, Baudenon J et al (2026) Lean tissue index and nutritional status in dialysis patients: insights from a large-scale observational study. Nutrition 141:112951. https:\/\/doi.org\/10.1016\/j.nut.2025.112951","journal-title":"Nutrition"},{"key":"3499_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 12:7\u201311. https:\/\/doi.org\/10.1016\/j.kisu.2021.11.003","journal-title":"Kidney Int Suppl"},{"key":"3499_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/ndt\/gfp437","volume":"25","author":"DH Krieter","year":"2010","unstructured":"Krieter DH, Hackl A, Rodriguez A et al (2010) Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transpl 25:212\u2013218. https:\/\/doi.org\/10.1093\/ndt\/gfp437","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"3499_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/toxins11010047","volume":"11","author":"DH Krieter","year":"2019","unstructured":"Krieter DH, Kerwagen S, R\u00fcth M et al (2019) Differences in dialysis efficacy have limited effects on protein-bound uremic toxins plasma levels over time. Toxins (Basel) 11(1):47. https:\/\/doi.org\/10.3390\/toxins11010047","journal-title":"Toxins (Basel)"},{"issue":"9","key":"3499_CR20","doi-asserted-by":"publisher","first-page":"16837","DOI":"10.20452\/pamw.16837","volume":"134","author":"J Lewkowicz","year":"2024","unstructured":"Lewkowicz J, Tankiewicz-Kwedlo A, Pawlak D et al (2024) Kynurenines in heart failure with preserved ejection fraction: an influence of type 2 diabetes. Pol Arch Intern Med 134(9):16837. https:\/\/doi.org\/10.20452\/pamw.16837","journal-title":"Pol Arch Intern Med"},{"key":"3499_CR21","doi-asserted-by":"publisher","first-page":"ii33","DOI":"10.1093\/ndt\/gfab223","volume":"37","author":"S Liabeuf","year":"2021","unstructured":"Liabeuf S, Pepin M, Franssen CFM et al (2021) Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle? Nephrol Dial Transpl 37:ii33\u2013ii44. https:\/\/doi.org\/10.1093\/ndt\/gfab223","journal-title":"Nephrol Dial Transpl"},{"key":"3499_CR22","doi-asserted-by":"publisher","first-page":"iii12","DOI":"10.1093\/ndt\/gfy224","volume":"33","author":"I Masakane","year":"2018","unstructured":"Masakane I, Sakurai K (2018) Current approaches to middle molecule removal: room for innovation. Nephrol Dial Transpl 33:iii12\u2013iii21. https:\/\/doi.org\/10.1093\/ndt\/gfy224","journal-title":"Nephrol Dial Transpl"},{"key":"3499_CR23","doi-asserted-by":"publisher","first-page":"117864692095488","DOI":"10.1177\/1178646920954882","volume":"13","author":"A Mor","year":"2020","unstructured":"Mor A, Kalaska B, Pawlak D (2020) Kynurenine pathway in chronic kidney disease: What\u2019s old, What\u2019s new, and What\u2019s next? Int J Tryptophan Res 13:117864692095488. https:\/\/doi.org\/10.1177\/1178646920954882","journal-title":"Int J Tryptophan Res"},{"key":"3499_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/cns.13768","volume":"28","author":"A Ostapiuk","year":"2022","unstructured":"Ostapiuk A, Urbanska EM (2022) Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword? CNS Neurosci Ther 28:19\u201335. https:\/\/doi.org\/10.1111\/cns.13768","journal-title":"CNS Neurosci Ther"},{"key":"3499_CR25","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.1007\/s00216-023-04926-x","volume":"415","author":"P Pallerla","year":"2023","unstructured":"Pallerla P, Ragi N, Gari ARBR et al (2023) Evaluation of amino acids and other related metabolites levels in end-stage renal disease (ESRD) patients on Hemodialysis by LC\/MS\/MS and GC\/MS. Anal Bioanal Chem 415:6491\u20136509. https:\/\/doi.org\/10.1007\/s00216-023-04926-x","journal-title":"Anal Bioanal Chem"},{"key":"3499_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1023\/A:1015238418500","volume":"33","author":"D Pawlak","year":"2001","unstructured":"Pawlak D, Pawlak K, Malyszko J et al (2001) Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol 33:399\u2013404. https:\/\/doi.org\/10.1023\/A:1015238418500","journal-title":"Int Urol Nephrol"},{"key":"3499_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-1-4615-0135-0_43","volume":"527","author":"D Pawlak","year":"2003","unstructured":"Pawlak D, Koda M, Wo\u0142czy\u0144ski S et al (2003) Mechanism of inhibitory effect of 3-hydroxykynurenine on erythropoiesis in patients with renal insufficiency. Adv Exp Med Biol 527:375\u2013380. https:\/\/doi.org\/10.1007\/978-1-4615-0135-0_43","journal-title":"Adv Exp Med Biol"},{"key":"3499_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MAJ.0b013e3181aa30e6","volume":"338","author":"K Pawlak","year":"2009","unstructured":"Pawlak K, Kowalewska A, Pawlak D, Mysliwiec M (2009a) Kynurenine and its metabolites\u2014kynurenic acid and anthranilic acid are associated with soluble endothelial adhesion molecules and oxidative status in patients with chronic kidney disease. Am J Med Sci 338:293\u2013300. https:\/\/doi.org\/10.1097\/MAJ.0b013e3181aa30e6","journal-title":"Am J Med Sci"},{"issue":"1","key":"3499_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1160\/TH08-10-0696","volume":"102","author":"K Pawlak","year":"2009","unstructured":"Pawlak K, Mysliwiec M, Pawlak D (2009b) Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients. Thromb Haemost 102(1):49\u201355. https:\/\/doi.org\/10.1160\/TH08-10-0696","journal-title":"Thromb Haemost"},{"issue":"12","key":"3499_CR30","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.3390\/ijms22126563","volume":"22","author":"K Pawlak","year":"2021","unstructured":"Pawlak K, Sieklucka B, Pawlak D (2021) Paracrine kynurenic pathway activation in the bone of young uremic rats can antagonize anabolic effects of PTH on bone turnover and strength through the disruption of PTH-dependent molecular signaling. Int J Mol Sci 22(12):6563. https:\/\/doi.org\/10.3390\/ijms22126563","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3499_CR31","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3390\/nu11122851","volume":"11","author":"A Post","year":"2019","unstructured":"Post A, Huberts M, Poppe E et al (2019) Tryptophan intake and tryptophan losses in hemodialysis patients: a balance study. Nutrients 11(12):2851. https:\/\/doi.org\/10.3390\/nu11122851","journal-title":"Nutrients"},{"key":"3499_CR32","doi-asserted-by":"publisher","first-page":"F565","DOI":"10.1152\/ajprenal.2000.279.3.F565","volume":"279","author":"K Saito","year":"2000","unstructured":"Saito K, Fujigaki S, Heyes MP et al (2000) Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Am J Physiol Ren Physiol 279:F565\u2013572. https:\/\/doi.org\/10.1152\/ajprenal.2000.279.3.F565","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6","key":"3499_CR33","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/ndt\/gfn739","volume":"24","author":"JC Schefold","year":"2009","unstructured":"Schefold JC, Zeden JP, Fotopoulou C et al (2009) Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transpl 24(6):1901\u20131908. https:\/\/doi.org\/10.1093\/ndt\/gfn739","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"3499_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/toxins11040235","volume":"11","author":"E Snauwaert","year":"2019","unstructured":"Snauwaert E, Holvoet E, Van Biesen W et al (2019) Uremic toxin concentrations are related to residual kidney function in the pediatric hemodialysis population. Toxins (Basel) 11(4):235. https:\/\/doi.org\/10.3390\/toxins11040235","journal-title":"Toxins (Basel)"},{"key":"3499_CR35","doi-asserted-by":"publisher","first-page":"632","DOI":"10.5301\/ijao.5000456","volume":"38","author":"J Sternby","year":"2015","unstructured":"Sternby J, Daugirdas JT (2015) Theoretical basis for and improvement of daugirdas\u2019 second generation formula for single-pool Kt\/V. Int J Artif Organs 38:632\u2013637. https:\/\/doi.org\/10.5301\/ijao.5000456","journal-title":"Int J Artif Organs"},{"key":"3499_CR36","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ajcn.82.2.342","volume":"82","author":"ME Suliman","year":"2005","unstructured":"Suliman ME, Qureshi AR, Stenvinkel P et al (2005) Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. Am J Clin Nutr 82:342\u2013349. https:\/\/doi.org\/10.1093\/ajcn.82.2.342","journal-title":"Am J Clin Nutr"},{"key":"3499_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0014-2999(92)90034-2","volume":"215","author":"Y Takao","year":"1992","unstructured":"Takao Y, Kamisaki Y, Itoh T (1992) Beta-adrenergic regulation of amine precursor amino acid transport across the blood-brain barrier. Eur J Pharmacol 215:245\u2013251. https:\/\/doi.org\/10.1016\/0014-2999(92)90034-2","journal-title":"Eur J Pharmacol"},{"key":"3499_CR38","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1124\/dmd.121.000486","volume":"49","author":"J Tang","year":"2021","unstructured":"Tang J, Shen H, Zhao X et al (2021) Endogenous plasma kynurenic acid in human: a newly discovered biomarker for drug-drug interactions involving organic anion transporter 1 and 3 Inhibition. Drug Metab Dispos 49:1063\u20131069. https:\/\/doi.org\/10.1124\/dmd.121.000486","journal-title":"Drug Metab Dispos"},{"key":"3499_CR39","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s40620-022-01388-9","volume":"35","author":"C Tanriover","year":"2022","unstructured":"Tanriover C, Ucku D, Basile C et al (2022) On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease. J Nephrol 35:2191\u20132204. https:\/\/doi.org\/10.1007\/s40620-022-01388-9","journal-title":"J Nephrol"},{"issue":"4","key":"3499_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/toxins12040234","volume":"12","author":"MK van Gelder","year":"2020","unstructured":"van Gelder MK, Middel IR, Vernooij RWM et al (2020) Protein-bound uremic toxins in hemodialysis patients relate to residual kidney function, are not influenced by convective transport, and do not relate to outcome. Toxins (Basel) 12(4):234. https:\/\/doi.org\/10.3390\/toxins12040234","journal-title":"Toxins (Basel)"},{"issue":"6","key":"3499_CR41","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.3390\/ijms24065373","volume":"24","author":"WB van Ham","year":"2023","unstructured":"van Ham WB, Cornelissen CM, Polyakova E et al (2023) Pro-Arrhythmic potential of accumulated uremic toxins is mediated via vulnerability of action potential repolarization. Int J Mol Sci 24(6):5373. https:\/\/doi.org\/10.3390\/ijms24065373","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3499_CR42","doi-asserted-by":"publisher","first-page":"14548","DOI":"10.1038\/s41598-019-51215-8","volume":"9","author":"J Wenninger","year":"2019","unstructured":"Wenninger J, Meinitzer A, Holasek S et al (2019) Associations between tryptophan and iron metabolism observed in individuals with and without iron deficiency. Sci Rep 9(1):14548. https:\/\/doi.org\/10.1038\/s41598-019-51215-8","journal-title":"Sci Rep"},{"key":"3499_CR43","doi-asserted-by":"publisher","unstructured":"Yang S, Datta D, Krienen FM et al (2024) Kynurenic acid inflammatory signaling expands in primates and impairs prefrontal cortical cognition. bioRxiv Prepr Serv Biol 2024. https:\/\/doi.org\/10.1101\/2024.06.13.598842","DOI":"10.1101\/2024.06.13.598842"},{"key":"3499_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s43440-021-00329-w","volume":"74","author":"I Zakrocka","year":"2022","unstructured":"Zakrocka I, Za\u0142uska W (2022) Kynurenine pathway in kidney diseases. Pharmacol Rep 74:27\u201339. https:\/\/doi.org\/10.1007\/s43440-021-00329-w","journal-title":"Pharmacol Rep"},{"key":"3499_CR45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jchromb.2010.01.006","volume":"878","author":"J Zhao","year":"2010","unstructured":"Zhao J, Gao P, Zhu D (2010) Optimization of Zn2+-containing mobile phase for simultaneous determination of kynurenine, kynurenic acid and tryptophan in human plasma by high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 878:603\u2013608. https:\/\/doi.org\/10.1016\/j.jchromb.2010.01.006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-026-03499-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-026-03499-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-026-03499-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:40:18Z","timestamp":1770964818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-026-03499-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3499"],"URL":"https:\/\/doi.org\/10.1007\/s00726-026-03499-0","relation":{},"ISSN":["1438-2199"],"issn-type":[{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Bioethical Committee at the Medical University, Lublin, Poland (number KE-0254\/61\/04\/2024 and KE-0254\/84\/05\/2024), and was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"All participants had enough time to read the study protocol, were informed about the aim of the study and gave the written informed consent to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"12"}}